Among the components in snake venom are a number which have profound e
ffects (either stimulatory or inhibitory) on haemostatic mechanisms, i
ncluding coagulation, fibrinolysis, platelet function and vascular int
egrity. As a consequence, human victims of snakebite may suffer severe
and sometimes fatal haemorrhagic and/or thrombotic sequelae. Many of
these venom components have been isolated and their precise mechanisms
of action established. Apart from direct fibrinolysins, procoagulants
predominate, most of these exerting their effect late in the clotting
cascade, activating factor X or prothrombin or directly converting fi
brinogen to fibrin. Some of the procoagulants are, or have the potenti
al to be, used as therapeutic agents. Some venom components have been
put to use as laboratory reagents for diagnostic purposes or for chara
cterising molecular defects of haemostasis, although because they ofte
n have unphysiological actions, results must be interpreted with cauti
on. These and other useful constituents e.g. protein C activator and p
latelet aggregating agents are discussed.